Values First Advisors’s Emergent Biosolutions EBS Stock Holding History

Values First Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.56M	Buy	307,880 +2,834	+0.9%	+$29.4K	1.33%	14
2025 Q4	$3.77M	Sell	305,046 -62,873	-17%	-$674K	1.96%	8
2025 Q3	$3.25M	Sell	367,919 -8,084	-2%	-$62.9K	1.74%	10
2025 Q2	$2.4M	Buy	376,003 +756	+0.2%	+$4.33K	1.31%	13
2025 Q1	$1.81M	Sell	375,247 -1,445	-0.4%	-$12K	1.06%	24
2024 Q4	$3.6M	Sell	376,692 -79,516	-17%	-$730K	1.98%	8
2024 Q3	$3.81M	Sell	456,208 -9,943	-2%	-$90.4K	2.07%	6
2024 Q2	$3.18M	Sell	466,151 -3,936	-0.8%	-$16.9K	1.9%	6
2024 Q1	$1.19M	Buy	470,087 +162,195	+53%	+$366K	0.7%	44
2023 Q4	$739K	Buy	307,892 +155,193	+102%	+$365K	0.45%	74
2023 Q3	$519K	Buy	152,699 +101,796	+200%	+$564K	0.34%	91
2023 Q2	$374K	Buy	50,903 +1,282	+3%	+$11.9K	0.23%	113
2023 Q1	$514K	Buy	49,621 +15,679	+46%	+$190K	0.33%	86
2022 Q4	$401K	Buy	33,942 +19,929	+142%	+$308K	0.28%	97
2022 Q3	$294K	Buy	+14,013	New	+$390K	0.21%	110
2022 Q2	–	Sell	-6,477	Closed	-$266K	–	161
2022 Q1	$266K	Buy	6,477 +976	+18%	+$43K	0.17%	133
2021 Q4	$239K	Buy	+5,501	New	+$249K	0.14%	144
2021 Q3	–	Sell	-3,593	Closed	-$226K	–	150
2021 Q2	$226K	Buy	+3,593	New	+$231K	0.15%	135

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Values First Advisors's EBS Position: Q1 2026 in Review

Values First Advisors increased its Emergent Biosolutions (EBS) stake by 0.93% in Q1 2026, buying an estimated $29.4K and bringing the position to 307,880 shares worth $2.56M. The position accounts for 1.33% of the portfolio, ranked #14.

Values First Advisors first reported a position in EBS in Q2 2021 and has held it in 18 quarters since. The position peaked at $3.81M in Q3 2024. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

Values First Advisors held 307,880 shares of Emergent Biosolutions worth $2.56M as of Q1 2026.
Values First Advisors bought 2,834 Emergent Biosolutions shares in Q1 2026, an estimated $29.4K.
Emergent Biosolutions made up 1.33% of Values First Advisors's portfolio in Q1 2026, its #14 holding.
Values First Advisors first reported a position in Emergent Biosolutions in Q2 2021 and has held it in 18 quarters since.
Values First Advisors's Emergent Biosolutions position peaked at $3.81M in Q3 2024.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Values First Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.